Your browser doesn't support javascript.
loading
Mss51 protein inhibition serves as a novel target for type 2 diabetes: a molecular docking and simulation study.
Ali, Shahid; Ahmad, Khurshid; Shaikh, Sibhghatulla; Chun, Hee Jin; Choi, Inho; Lee, Eun Ju.
Affiliation
  • Ali S; Department of Medical Biotechnology, Yeungnam University, Gyeongsan, South Korea.
  • Ahmad K; Research Institute of Cell Culture, Yeungnam University, Gyeongsan, South Korea.
  • Shaikh S; Department of Medical Biotechnology, Yeungnam University, Gyeongsan, South Korea.
  • Chun HJ; Research Institute of Cell Culture, Yeungnam University, Gyeongsan, South Korea.
  • Choi I; Department of Medical Biotechnology, Yeungnam University, Gyeongsan, South Korea.
  • Lee EJ; Research Institute of Cell Culture, Yeungnam University, Gyeongsan, South Korea.
J Biomol Struct Dyn ; : 1-8, 2023 Jun 20.
Article in En | MEDLINE | ID: mdl-37338036
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Biomol Struct Dyn Year: 2023 Document type: Article Affiliation country: South Korea
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: J Biomol Struct Dyn Year: 2023 Document type: Article Affiliation country: South Korea